Bhupesh Bhandari The Ranbaxy

Rediff.com » News » Bhupesh Bhandari The Ranbaxy

News for Bhupesh Bhandari The Ranbaxy

Business

Ranbaxy's dark chapter

Why have Indian authorities woken up to the Ranbaxy case only now? The matter had been simmering for several years, notes Bhupesh Bhandari The Ranbaxy affair is one of the darkest chapters of......

What went wrong with Ranbaxy

The company’s reputation has taken such a beating in the last few months that any attempt at image management will be an uphill task, says Bhupesh Bhandari. Yet another factory of......

'Ranbaxy will always be run independently'

The open offer from Daiichi Sankyo of Japan for 20 per cent of Ranbaxy Laboratories' shares closed last week and another milestone in the acquisition of India's largest pharmaceuticals company was......

Sun Pharma has all the reasons to cheer Ranbaxy deal

There is a global movement towards generics and every patent-driven company wants a piece of the action, says Bhupesh Bhandari. In Sun Pharma's acquisition of Ranbaxy, what seems to have caught......

Future's bright for Indian pharma cos

Davinder Singh Brar, who helped build Ranbaxy from scratch, today has a 50 per cent interest in GVK Biosciences and is advising Temasek of Singapore and Teva of Israel on their India strategies.In......

Bhupesh Bhandari The Ranbaxy

News for Bhupesh Bhandari The Ranbaxy

Ranbaxy's dark chapter

What went wrong with Ranbaxy

'Ranbaxy will always be run independently'

Sun Pharma has all the reasons to cheer Ranbaxy deal

Future's bright for Indian pharma cos

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS